CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Erin A. McClure

OPENALEX: A5008888266↗ORCID: 0000-0001-9744-7818↗

Affiliations

Organizations

Behavioral Pharma (United States)authorship · US Johns Hopkins Universityauthorship · US Medical University of South Carolinaauthorship · US Middle Tennessee State Universityauthorship · US MUSC Hollings Cancer Centerauthorship · US Ontario Institute for Cancer Researchauthorship · CA Ralph H. Johnson VA Medical Centerauthorship · US Roswell Park Comprehensive Cancer Centerauthorship · US University of Waterlooauthorship · CA

Public evidence

4 connected articles

Evaluating racial disparities in cancer patient-provider communication about cannabis in a state without a legal cannabis marketplace.2025 · Europe PMC Associations of Cannabis Use, High-Risk Alcohol Use, and Depressive Symptomology with Motivation and Attempts to Quit Cigarette Smoking Among Adults: Findings from the 2020 ITC Four Country Smoking and Vaping Survey.2025 · Europe PMC N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings.2025 · Europe PMC Determining the impact of cannabis use and severity on tobacco cessation outcomes: study protocol for a prospective tobacco treatment trial.2023 · PubMed Central Open Access

Registered research

Connected studies

A Prospective Trial of Varenicline and Incentives for Tobacco Cessation in Adultsnct04228965 N-Acetylcysteine for Youth Cannabis Use Disordernct03055377

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Erin A. McClure - Medical Cannabis Research Engine